4. Summary
Employment of cardiac MRI techniques (cine MRI, wall thickening analysis, quantitative MRFPP, MR tissue tagging) allowed non-invasive localization and assessment of early and late changes in myocardial function and perfusion produced by these new approaches of myocardial revascularization. With its precision in assessment of myocardial perfusion and collateral-dependent territories, cardiac MRI techniques may be of excellent use for the evaluation of effects on myocardial function and perfusion as well as longitudinal outcomes in clinical trials with TMLR and angiogenesis therapies in patients with CAD. As growth factor therapies approach phase III clinical trials, such vital questions as the most effective delivery system, dosages and techniques used for treatment-monitoring parameters remain unanswered. In addition, better definitions of patient selection criteria for TMLR and angiogenesis therapies for both short- and long-term maximum benefits are needed at this time. Large-scale clinical trials with cardiac MRI techniques are needed to reliably assess functional and perfusion reserves of the myocardium pre and post TMLR and angiogenesis therapies. MR-based outcome parameters may aid in answering questions pertinent to the new revascularization treatments.
Similar content being viewed by others
References
Allen KB, et al. New Engl J Med 1999;341:1029–36.
Frazier OH, et al. New Engl J Med 1999;341:1021–8.
Whittaker P, et al. Lasers Surg Med 1999;24:253–60.
Yamamoto N, et al. J Am Coll Cardiol 1998;31:1426–33.
Kohmoto T, et al. Ann Thorac Surg 1998;65:1360–7.
Gassler N, et al. Circulation 1997;95:371–5.
Horvath KA, et al. J Am Coll Cardiol 1995;25:258–63.
Mirhoseini M, et al. J Clin Laser Med Surg 1990;8:73–7.
Hughes GC, et al. Circulation 1999;100:249.
Hughes GC, et al. Ann Thorac Surg 1999;67:1714–20.
Nagel E, et al. Circulation 1999;99:763–70.
Wilke N, et al. Magn Reson Med 1993;29:485–97.
Al Saadi N, et al. Circulation 2000;101:1379–83.
Muehling O, et al., J Am Coll Cardiol 2000;35.
Wilke N, et al. Suppl Circ 1997;98:1–373.
Dutcher J, et al. JCMRI 1999;3:273.
Dutcher J, et al. JCMRI 1999;3:286.
Kadipasaoglu KA, et al. Ann Thorac Surg 1999;67:423–31.
Lewis BS, et al. Cardiovasc Res 1997;35:490–7.
Henry TD, Br Med J 1999;318:1536–9.
Folkman J, Shing Y, J Biol Chem 1992;267:10931–4.
Isner JM, et al. Lancet 1996;348:370–4.
Schumaker B, et al. Circulation 1998;97:645–50.
Banai S, et al. Circulation 1994;89:2183–9.
Hashimoto E, et al. Am J Physiol 1994;267:1948–54.
Pepper MS, et al. Biochem Biophys Res Commun 1992;3:211–20.
Hariwala M, et al. J Surg Res 1996;63:77–82.
Vale PR, et al. Circulation 1999;100:1–447.
Bauters C, et al. J Vasc Surg 1995;21:314–25.
Folkman J, et al. New Engl J Med 1995;333:1757–63.
Cuevas P, et al. Circ Res 1991;69:360–9.
Ware J, Simons M. Nat Med 1997;3:158–64.
Baffour R, et al. J Vasc Surg 1992;16:181–91.
Yanagisawa-Miwa A, et al. Science 1992;257:1401–3.
Unger EF, et al. Am J Physiol 1994;266:1588–96.
Takeshira S, et al. Circulation 1994;90:228–34.
Banai S, et al. Cardiovasc Res 1994;28:1176–9.
Henry TD, et al. J Am Coll Cardiol 1998;31:65A.
Losordo DW, et al. Circulation 1998;98:2800–4.
Symes JF, et al. Ann Thorac Surg 1996;68:803–6.
Henry TD, et al. Suppl Circ 1999;100:1–446.
Hendel RC, et al. Circulation 2000;101:118–21.
Tsui B, et al. J Nucl Cardiol 1998;5:507–22.
Zenovich A, et al. JCMRI 1999;4:346–7.
Jerosch-Herold M, Int J Card Imaging 1997;13:205–18.
Wilke N, et al. JCMRI 1999;4:388–9.
Wilke N, et al. Suppl Circ 1999;100:1–227.
Pearlman JD, et al. Acad Radiol 1997;4:680–6.
Freedman SB, et al. Circulation 1985;71:681–6.
Pearlman JD, et al. Nat Med 1995;1:1085–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wilke, N.M., Zenovich, A., Muehling, O. et al. Novel revascularization therapies — TMLR and growth factor-induced angiogenesis monitored with cardiac MRI. MAGMA 11, 61–64 (2000). https://doi.org/10.1007/BF02678497
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02678497